Scott G. Filler, Marie-Claude Ouimet, Stefanie D. Baptista, Ilia Kravtsov, Paolo Campoli, Thierry Fontaine, Mirjam Urb, Qusai Al Abdallah, Jean-Paul Latgé, Melanie Lehoux, Hong Liu, Anne Beauvais, Ghyslaine Vanier, Christopher M.-Q. Hoareau, Jörg H. Fritz, Josée C. Chabot, Dan Chen, William C. Nierman, Fabrice N. Gravelat, Aaron P. Mitchell, Brendan D. Snarr, Donald C. Sheppard, Wenjie Xu, Mark J. Lee, McGill University = Université McGill [Montréal, Canada], Aspergillus, Institut Pasteur [Paris] (IP), University of California [Los Angeles] (UCLA), University of California (UC), J. Craig Venter Institute, Carnegie Mellon University [Pittsburgh] (CMU), David Geffen School of Medicine [Los Angeles], University of California (UC)-University of California (UC), This work was supported in part by grant number R01AI073829, as well as contract no. N01-AI-30041 from the National Institutes of Health (NIH), USA, and by operating grants from the Canadian Institutes of Health Research (CIHR) and Cystic Fibrosis Canada. DCS was supported by a Clinician Scientist award from the CIHR and a Chercheur-Clinicien award from the Fonds de Recherche en Santé du Québec (FRSQ). Research in the Aspergillus unit at the Institut Pasteur was supported by grant AntiFun from the ERANet Pathogenomic program, from the European Community's Seventh Framework Programme [FP7-2007-2013] under grant agreement n° HEALTH-F2-2010-260338 –ALLFUN and from Agence Nationale de la Recherche (ANR-06-EMPB-011-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., ANR-06-EMPB-0011,GALNACGAL,Développement d'un nouveau test de diagnostic de l'aspergillose(2006), European Project: 260338,EC:FP7:HEALTH,FP7-HEALTH-2010-single-stage,ALLFUN(2010), Institut Pasteur [Paris], University of California, University of California-University of California, and Doering, Tamara L
Aspergillus fumigatus is the most common cause of invasive mold disease in humans. The mechanisms underlying the adherence of this mold to host cells and macromolecules have remained elusive. Using mutants with different adhesive properties and comparative transcriptomics, we discovered that the gene uge3, encoding a fungal epimerase, is required for adherence through mediating the synthesis of galactosaminogalactan. Galactosaminogalactan functions as the dominant adhesin of A. fumigatus and mediates adherence to plastic, fibronectin, and epithelial cells. In addition, galactosaminogalactan suppresses host inflammatory responses in vitro and in vivo, in part through masking cell wall β-glucans from recognition by dectin-1. Finally, galactosaminogalactan is essential for full virulence in two murine models of invasive aspergillosis. Collectively these data establish a role for galactosaminogalactan as a pivotal bifunctional virulence factor in the pathogenesis of invasive aspergillosis., Author Summary Invasive aspergillosis is the most common mold infection in humans, predominately affecting immunocompromised patients. The mechanisms by which the mold Aspergillus fumigatus adheres to host tissues and causes disease are poorly understood. In this report, we compared mutants of Aspergillus with different adhesive properties to identify fungal factors involved in adherence to host cells. This approach identified a cell wall associated polysaccharide, galactosaminogalactan, which is required for adherence to a wide variety of substrates. Galactosaminogalactan was also observed to suppress inflammation by concealing β-glucans, key pattern associated microbial pattern molecules in Aspergillus hyphae, from recognition by the innate immune system. Mutants that were deficient in galactosaminogalactan were less virulent in mouse models of invasive aspergillosis. These data identify a bifunctional role for galactosaminogalactan in the pathogenesis of invasive aspergillosis, and suggest that it may serve as a useful target for antifungal therapy.